Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/11118
DC FieldValueLanguage
dc.contributor.authorTatjana Milenkovicen_US
dc.contributor.authorMirjana Kocovaen_US
dc.contributor.authorBrankica Krstevskaen_US
dc.contributor.authorGordana Pemovskaen_US
dc.contributor.authorIvica Smokovskien_US
dc.date.accessioned2021-03-22T10:18:57Z-
dc.date.available2021-03-22T10:18:57Z-
dc.date.issued2016-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11118-
dc.language.isoenen_US
dc.publisherMary Ann Lieberten_US
dc.relation.ispartofDiabetes Technology & Therapeuticsen_US
dc.titleComment on Publications from OpT2mise Studyen_US
dc.typeArticleen_US
dc.identifier.doi10.1089/dia.2016.0064-
dc.identifier.volume18-
dc.identifier.issue7-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

176
checked on 3.5.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.